Xometry (NASDAQ:XMTR – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $120.00 to $140.00 in a research note issued to investors on Wednesday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.
A number of other research firms also recently issued reports on XMTR. Wedbush raised their price target on shares of Xometry from $126.00 to $140.00 and gave the company an “outperform” rating in a report on Wednesday. The Goldman Sachs Group lifted their price target on shares of Xometry from $78.00 to $104.00 and gave the company a “neutral” rating in a research report on Wednesday, August 5th. Cantor Fitzgerald boosted their price objective on shares of Xometry from $110.00 to $114.00 and gave the stock an “overweight” rating in a research note on Wednesday. Citigroup reissued a “market outperform” rating on shares of Xometry in a research report on Monday, September 21st. Finally, Royal Bank Of Canada lifted their target price on shares of Xometry from $100.00 to $117.00 and gave the company a “hold” rating in a report on Wednesday. Eight analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $123.64.
View Our Latest Stock Analysis on XMTR
Xometry Trading Up 5.4%
NASDAQ:XMTR traded up $5.94 during trading hours on Wednesday, reaching $114.95. 1,101,668 shares of the company were exchanged, compared to its average volume of 746,134. The firm has a market cap of $5.96 billion, a price-to-earnings ratio of -338.08 and a beta of 1.33. The stock has a 50 day simple moving average of $98.21 and a 200 day simple moving average of $77.22. Xometry has a 52-week low of $35.86 and a 52-week high of $117.94. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.21 and a quick ratio of 3.20.
Xometry (NASDAQ:XMTR – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09. Xometry had a negative return on equity of 2.88% and a negative net margin of 3.82%. The business had revenue of $252.44 million during the quarter, compared to the consensus estimate of $235.54 million. During the same period in the prior year, the firm posted $0.11 EPS. The business’s revenue for the quarter was up 39.5% on a year-over-year basis. As a group, analysts predict that Xometry will post -0.01 EPS for the current year.
Insider Activity
In related news, CTO Vaidyanathan Raghavan sold 1,866 shares of the firm’s stock in a transaction on Friday, October 2nd. The shares were sold at an average price of $103.28, for a total transaction of $192,720.48. Following the completion of the sale, the chief technology officer directly owned 133,911 shares of the company’s stock, valued at approximately $13,830,328.08. This trade represents a 1.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katharine Weymouth sold 5,000 shares of Xometry stock in a transaction on Monday, August 31st. The stock was sold at an average price of $95.23, for a total transaction of $476,150.00. Following the sale, the director directly owned 35,345 shares in the company, valued at $3,365,904.35. This trade represents a 12.39% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 73,199 shares of company stock worth $7,126,855. Company insiders own 9.10% of the company’s stock.
Institutional Trading of Xometry
Large investors have recently modified their holdings of the business. Russell Investments Group Ltd. grew its stake in Xometry by 86.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 224,048 shares of the company’s stock valued at $23,044,000 after purchasing an additional 103,827 shares in the last quarter. Pictet Asset Management Holding SA raised its position in shares of Xometry by 7.6% in the 3rd quarter. Pictet Asset Management Holding SA now owns 7,203 shares of the company’s stock valued at $741,000 after purchasing an additional 508 shares in the last quarter. Integrity Alliance LLC. purchased a new position in shares of Xometry during the 3rd quarter valued at approximately $252,000. IPG Investment Advisors LLC boosted its stake in shares of Xometry by 34.4% during the 3rd quarter. IPG Investment Advisors LLC now owns 3,361 shares of the company’s stock valued at $346,000 after buying an additional 861 shares during the last quarter. Finally, ProShare Advisors LLC boosted its stake in shares of Xometry by 7.4% during the 3rd quarter. ProShare Advisors LLC now owns 6,507 shares of the company’s stock valued at $669,000 after buying an additional 446 shares during the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.
Xometry News Roundup
Here are the key news stories impacting Xometry this week:
- Positive Sentiment: Several firms—including UBS, Cantor Fitzgerald, Citizens JMP, Rosenblatt, Citigroup, JPMorgan and RBC—issued favorable outlooks or raised price targets, reinforcing expectations for further share appreciation. UBS analyst outlook Cantor Fitzgerald outlook Citizens JMP outlook Rosenblatt price target Citigroup outlook JPMorgan outlook RBC price target
- Positive Sentiment: Recent Seeking Alpha commentary describes Xometry’s growth thesis as playing out and the business as powering ahead, adding to the optimistic narrative. Xometry: The Thesis Is Playing Out Xometry Powers Ahead
- Positive Sentiment: A report points to GAAP profitability, a $1 billion revenue run rate and a Siemens partnership expected to support margin gains in 2027. Separately, the latest reported quarter beat analyst expectations for EPS and revenue, with revenue up 39.5% year over year. Profitability, revenue run rate and Siemens partnership report
- Neutral Sentiment: The profitability outlook is not yet unambiguous: the supplied quarterly figures also show a negative net margin, so investors may look for sustained earnings improvement to validate the bullish case.
Xometry Company Profile
Xometry, Inc (NASDAQ:XMTR) operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.
The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.
Recommended Stories
- Five stocks we like better than Xometry
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.
